GET THE APP

Medical and Pharmaceutical Research Using Artificial Intelligence
..

Research and Reports in Medical Sciences

ISSN: 2952-8127

Open Access

Opinion - (2022) Volume 6, Issue 5

Medical and Pharmaceutical Research Using Artificial Intelligence

Sándor Lenk*
*Correspondence: Sándor Lenk, Department of Pharmaceutical Technology, International Medical University, Kuala Lumpur, Malaysia, Email:
Department of Pharmaceutical Technology, International Medical University, Kuala Lumpur, Malaysia

Received: 01-Sep-2022, Manuscript No. rrms-23-86767; Editor assigned: 03-Sep-2022, Pre QC No. P-86767; Reviewed: 15-Sep-2022, QC No. Q-86767; Revised: 20-Sep-2022, Manuscript No. R- 86767; Published: 27-Sep-2022 , DOI: 10.37421/2952-8127.2022.6.89
Citation: Lenk, Sándor. “Medical and Pharmaceutical Research Using Artificial Intelligence.” Res Rep Med Sci 6 (2022): 89.
Copyright: © 2022 Lenk S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

A field of computer science called artificial intelligence gives robots the ability to operate effectively and understand complicated data. The amount of research on AI has grown significantly, and its application to healthcare services and research is progressing more quickly. The advantages and disadvantages of AI in medical and pharmaceutical research are discussed in detail in this article. In order to select the research and review articles published within the last five years, the literature was gathered from sources like PubMed, Science Direct, and Google Scholar using specific keywords and phrases like "Artificial intelligence," "Pharmaceutical research," "drug discovery," "clinical trial," and "disease diagnosis." This article provided a thorough assessment of the use of in illness diagnosis, digital therapy, individualised treatment, drug development, and pandemic or epidemic forecasting [1].

The most common AI technologies are deep learning and neural networks; Bayesian nonparametric models are a viable technology for clinical trial design; wearable devices and natural language processing are employed for patient identification and clinical trial monitoring. Deep learning and neural networks were used to forecast the emergence of Zika, Ebola, and seasonal flu. With the development of AI technology, the scientific community may see quick and affordable medical and pharmaceutical research as well as better public services [2].

Artificial intelligence refers to a variety of intelligent behaviours and processes that have been generated using computer models, algorithms, or a set of rules that enable machines to replicate human cognitive abilities like learning, problem-solving, etc. Clinical decision-making, illness detection, and automation are all significantly impacted by AI's rapid penetration into the healthcare industry. Because AI can examine vast amounts of data from many different modalities, there are prospects for it to be used in pharmaceutical and healthcare research Several recent studies go into detail on how AI is used in the healthcare industry and other industries.In the healthcare sector, artificial intelligence technologies such as machine learning l, natural language processing physical robots, and robotic. Neural network models and deep learning with a variety of characteristics are being applied in ML to imaging data to detect clinically relevant aspects at the early stages, notably in cancer-related diagnosis o understand and interpret human speech, employs computer methods. Recently, ML techniques have been widely incorporated into NLP for exploring unstructured data in databases and records such as doctor's notes, lab reports, etc. by mapping the critical information from various imagery and textual data that aids in decision making regarding diagnosis and treatment options. As disruptive innovation continues, a road is opened up for patients to get speedy and accurate diagnoses as well as specialised therapeutic strategies Platforms that can create AI-based solutions [3].

Description

The output of the prior analysis is processed as the input for the subsequent analysis. SVMs are employed for input data categorization and regression. AI is being utilized in the creation of pharmaceutical products to pick the best excipients, decide on the development method, and make sure the specifications are met throughout the procedure. The creation of pharmaceutical products makes use of A pandemic or AI. The papers pertaining to the use of AI in commercialization, market analysis, customer service, education, pharmaceutical production, and anything else unrelated to healthcare/pharmaceutical research are not included in this study. Using certain keywords, all the studies are searched on websites like PubMed, Science Direct, and Google Scholar. Disease analysis becomes essential for developing a thoughtful treatment plan and ensuring patients' wellbeing. Accurate diagnosis is hampered by human error, and misunderstanding of the generated information makes the work difficult and time-consuming. By ensuring accuracy and efficiency, AI may be applied in many different ways. Following a thorough review of the literature, applications of various technologies and approaches for illness diagnosis have been documented. According to many environmental expressions, as the human population grows, there is a constant rise in the need for the healthcare system [4].

The creation of new methodologies can define the applicability by illustrating the present existing situation that has not been covered, despite the existence of vulnerable, contradictory, and non-analyzing incongruities. This is supported by a considerable body of data. The classification of patients according to how badly they are impacted by their illnesses is crucial, and here is where artificial intelligence may play a significant role in diagnosis. The term "diagnosis" refers to the process through which one's ailment is identified based on certain pre-existing issues. It is usually advisable to keep track of each patient's health report forms in order to compile the majority of evaluations that come from conducting exams and tests. The right decisions are made based on information gathered, primarily in relation to the medical requirements for a prompt diagnosis.

Based on a review of the literature, clinical aspects that can oversee the neural pathways and deep learning network using support vector machines, nearest neighbours, random forests, decision trees, logistic regression, naive Bayes, discriminate analysis, and convolution neural networks can produce results in a more comprehensive manner. The origin, sample size, and number of features in the training and testing samples may all be used to undertake algorithm-based performance-driven analysis. Decision trees and reasoning were combined in the detection of liver disorders .Predictive modelling was the subject of several research, which were evident in their ability to forecast early Parkinson's disease. For the purpose of diagnosing lung disorders, the rib segmentation method was created .Rib-wise segmentation of X-ray pictures cannot be accomplished using conventional techniques.

This study, an algorithm was created by adding unpaired samples to chest X-ray pictures of pneumonia patients. A multi-scale network then learned the properties of the images. According to the study, this method performs well with improved rib segmentation and may be helpful in the diagnosis of lung cancer and other lung disorders .Researchers have recently employed algorithms and machine learning to classify and identify heart arrhythmias by analysing information. In a different study, the support vector machine classifier and optimization genetic algorithm were used to categorise and diagnose [5].

Conclusion

Recent advancements in AI have scientists enthralled, especially when it comes to how it is being used for medical and pharmaceutical research and services. The future of healthcare will be shaped by smart hospitals and healthcare facilities that are equipped with Data. Artificial intelligence will present a chance to reduce the price and duration of medication development in the pharmaceutical industry, which are constantly making technological advancements. lists several AI uses in medical and pharmaceutical research as well as the constraints and difficulties these technologies face. By utilising deep learning, neural networking, and unsupervised learning, the function of AI in illness detection is effectively illustrated. These AI systems can analyse unstructured data and link it with previously learnt data to accurately anticipate outcomes. . These AI technologies can analyse unstructured data and compare it to learnt data to accurately anticipate a result, which is helpful in determining the diagnosis of a certain condition. Intelligent computer-assisted instruction, case-based reasoning, vector regression approach, and clinical decision support are just a few examples of how AI has been shown to be a crucial tool for chronic illness monitoring and therapy optimization. In order to obtain an informative response from patients, computer-assisted instruction is helpful in identifying the relationships between variables. Case-based reasoning aids in problem solving by drawing on previous, analogous experiences, and clinical decision support gives the healthcare team patient-specific information and knowledge to aid in monitoring and treating a disease.

Acknowledgement

None.

Conflict of Interest

There is no conflict of interest by author.

References

  1. Hamet, Pavel and Johanne Tremblay. "Artificial intelligence in medicine." Metab 69 (2017): S36-S40.
  2. Google Scholar, Crossref, Indexed at

  3. Malik, Paras, Monika Pathania and Vyas Kumar Rathaur. "Overview of artificial intelligence in medicine."J Fam Med Prim Care Rev 8 (2019): 2328.
  4. Google Scholar, Crossref, Indexed at

  5. Haleem, Abid, Mohd Javaid and Ibrahim Haleem Khan. "Current status and applications of artificial intelligence (AI) in medical field: An overview." Curr Med Res Pract 9 (2019): 231-237.
  6. Google Scholar, Crossref, Indexed at

  7. Zhavoronkov, Alex, Quentin Vanhaelen and Tudor I. Oprea. "Will artificial intelligence for drug discovery impact clinical pharmacology?." Clin Pharmacol Ther 107 (2020): 780-785.
  8. Google Scholar, Crossref, Indexed at

  9. Masters, Ken. "Artificial intelligence in medical education." Med Teach 41 (2019): 976-980.
  10. Google Scholar, Crossref, Indexed at

arrow_upward arrow_upward